NovaBay Pharmaceuticals Inc banner
N

NovaBay Pharmaceuticals Inc
AMEX:SDEV

Watchlist Manager
NovaBay Pharmaceuticals Inc
AMEX:SDEV
Watchlist
Price: 1.65 USD 15.38%
Market Cap: $43.9m

P/S

79.9
Current
40 630%
More Expensive
vs 3-y average of 0.2

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
79.9
=
Market Cap
$35.3m
/
Revenue
$521k

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
79.9
=
Market Cap
$35.3m
/
Revenue
$521k

P/S Valuation Scenarios

NovaBay Pharmaceuticals Inc is trading above its 3-Year Average

If P/S returns to its 3-Year Average (0.2), the stock would be worth $0 (100% downside :side from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
98%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 79.9 $1.65
0%
3-Year Average 0.2 $0
-100%
5-Year Average 0.4 $0.01
-100%
Industry Average 2.7 $0.05
-97%
Country Average 2.4 $0.05
-97%

Forward P/S
Today's price vs future Revenue

Current Market Cap Revenue Forward P/S
$35.3m
/
Dec 2025
$521k
=
79.9
Current
$35.3m
/
Dec 2026
$16.2m
=
2.2
Forward

Forward P/S shows whether today's P/S still looks high or low once future Revenue are taken into account.

Peer Comparison

Market Distribution

NovaBay Pharmaceuticals Inc
Glance View

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett